Q4 & FY22 Highlights

Table of Contents Company Overview Investment Highlights Q4 & FY22 Highlights 4 6 23 DLPL Strategy for Future Growth 33 DISCLAIMER: This presentation may contain 'forward-looking' statements at places. The Company's business operations remain subject to Classification: Restricted undetermined contingencies and risks. Dr. Lal PathLabs Limited would not be liable for any action undertaken based on such 'forward-looking' 3 statements and does not commit to revising/updating them publicly. Dr Lal PathLabs

View entire presentation